Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 8:51 pm Purchase | 2024-09-30 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 133,404 3.900% | 133,404 (New Position) | Filing History |
| 2024-04-05 4:10 pm Purchase | 2024-03-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 133,547 5.900% | 133,547 (New Position) | Filing History |
| 2024-03-19 11:20 am Sale | 2024-01-12 | 13G | TRACON Pharmaceuticals, Inc. TCON | aaronson wayne | 35,846 2.300% | -53,076 (-59.69%) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Lincoln Park Capital Fund LLC | 5,841 0.375% | -112,650 (-95.07%) | Filing History |
| 2024-02-09 4:05 pm Sale | 2023-12-31 | 13D | TRACON Pharmaceuticals, Inc. TCON | Opaleye Management Inc. | 0 0.000% | -125,919 (Position Closed) | Filing History |
| 2023-06-02 4:46 pm Purchase | 2023-05-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Lincoln Park Capital Fund LLC | 118,491 8.980% | 118,491 (New Position) | Filing History |
| 2023-02-14 12:57 pm Purchase | 2022-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 138,277 12.500% | 3,721 (+2.77%) | Filing History |
| 2023-02-10 2:07 pm Purchase | 2022-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | aaronson wayne | 88,923 8.170% | 15,617 (+21.30%) | Filing History |
| 2022-04-29 5:17 pm Purchase | 2022-04-12 | 13G | TRACON Pharmaceuticals, Inc. TCON | aaronson wayne | 73,306 7.000% | 73,306 (New Position) | Filing History |
| 2022-02-14 4:37 pm Sale | 2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 134,556 13.800% | -1,287 (-0.95%) | Filing History |
| 2022-01-27 4:03 pm Unchanged | 2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Linden Capital L.P. | 46,080 4.600% | 0 (Unchanged) | Filing History |
| 2021-03-10 9:40 pm Sale | 2020-08-05 | 13D | TRACON Pharmaceuticals, Inc. TCON | New Enterprise Associates 14, L.P. | 0 0.000% | -17,844 (Position Closed) | Filing History |
| 2021-02-16 3:09 pm Sale | 2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | 683 Capital Management, LLC | 9,945 1.300% | -3,000 (-23.18%) | Filing History |
| 2021-02-16 08:33 am Purchase | 2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 135,842 17.800% | 27,715 (+25.63%) | Filing History |
| 2021-02-12 5:20 pm Purchase | 2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Opaleye Management Inc. | 125,919 17.040% | 125,919 (New Position) | Filing History |
| 2021-02-09 3:17 pm Purchase | 2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Linden Capital L.P. | 46,080 6.000% | 46,080 (New Position) | Filing History |